tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chi Fong, 8 are a HOLD (80%), 2 are a BUY (20%).
Analyst Chi Fong, currently employed at BAML, carries an average stock price target met ratio of 58.33% that have a potential upside of 15.52% achieved within 71 days.
Chi Fong’s has documented 19 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ROIV, Roivant Sciences Ltd at 21-Oct-2025.
Analyst best performing recommendations are on ROIV (ROIVANT SCIENCES LTD).
The best stock recommendation documented was for ROIV (ROIVANT SCIENCES LTD) at 6/23/2023. The price target of $11 was fulfilled within 17 days with a profit of $1.2 (12.24%) receiving and performance score of 7.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-May-2026
$55
$19.28 (53.98%)
$41
28 days ago
(09-Sep-2026)
1/2 (50%)
$13.19 (31.55%)
110
Buy Since 17-Oct-2023
$46
$10.28 (28.78%)
$42
28 days ago
(09-Sep-2026)
5/7 (71.43%)
$4.19 (10.02%)
323
Buy Since 14-Feb-2023
$47
$11.28 (31.58%)
$41
29 days ago
(08-Sep-2026)
26/27 (96.3%)
$5.52 (13.31%)
423
Buy Since 27-Sep-2023
$52
$16.28 (45.58%)
$20
29 days ago
(08-Sep-2026)
2/3 (66.67%)
$10.52 (25.36%)
393
Buy Since 02-Sep-2025
$46
$10.28 (28.78%)
$42
1 months 27 days ago
(10-Aug-2026)
4/6 (66.67%)
$10.22 (28.56%)
91
What Year was the first public recommendation made by Chi Fong?
